- Home
- ONDS vs INDV Comparison
ONDS vs INDV Comparison
Compare ONDS & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONDS | INDV |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ONDS | INDV |
|---|---|---|
| Price | $7.89 | $40.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $19.83 | N/A |
| AVG Volume (30 Days) | ★ 101.5M | 1.6M |
| Earning Date | 05-15-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | 0.56 | ★ 0.69 |
| Revenue | $50,731,000.00 | ★ $1,239,000,000.00 |
| Revenue This Year | $662.14 | N/A |
| Revenue Next Year | $76.37 | N/A |
| P/E Ratio | ★ $14.16 | $58.71 |
| Revenue Growth | ★ 605.31 | 4.29 |
| 52 Week Low | $1.78 | $16.69 |
| 52 Week High | $15.28 | $42.81 |
Technical Indicators
Market Signals| Indicator | ONDS | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 53.87 |
| Support Level | $7.46 | $39.20 |
| Resistance Level | $8.32 | $41.42 |
| Average True Range (ATR) | 0.56 | 1.37 |
| MACD | 0.18 | -0.15 |
| Stochastic Oscillator | 68.33 | 56.03 |
Price Performance
Historical ComparisonAbout ONDS Ondas Holdings Inc.
Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).